AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.

Holding(s) in Company

Total Voting Rights

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

AstraZeneca PLC (AZN LN)

Holding(s) in Company

Total Voting Rights

Imfinzi approved in US for early gastric cancer

AstraZeneca manufacturing investment in Maryland

Koselugo (selumetinib) approved in the US

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)